This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Washington University, Apath, LLC, Quidel Corporation. Active years: 1995-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Clayton, MO (US) (2014)
- St. Louis, MO (US) (1995 - 2015)
Company Filing History:



Years Active: 1995-2026
Title: **Inventor Paul D. Olivo: Pioneering Innovations in Autoantibody Detection**
Introduction
Paul D. Olivo, an accomplished inventor based in St. Louis, MO, has made significant contributions to the field of medical diagnostics with a total of 14 patents to his name. His work particularly focuses on the detection of autoantibodies, which play a critical role in various diseases, enabling clinicians to make informed decisions regarding treatment and monitoring.
Latest Patents
Among his latest innovations, Olivo has developed compositions and methods for detecting thyroid hormone blocking immunoglobulin (TBI). These methods are notable for their sensitivity and specificity concerning TBI and the dual detection of both TBI and thyroid-stimulating immunoglobulin (TSI). The implications of his inventions extend to the diagnosis of diseases associated with TBI and/or TSI, monitoring disease progression, treatment regimens, and the development of therapeutics and vaccines. His work aims to assist healthcare professionals in making critical treatment decisions based on accurate and reliable tests.
Career Highlights
Olivo's impressive career includes key roles at reputable institutions such as Washington University and Apath, LLC, where he has honed his expertise in biomedical innovation. His patents reflect a strong commitment to improving healthcare outcomes through scientific advancements and practical applications in diagnostics.
Collaborations
Throughout his career, Paul D. Olivo has collaborated with esteemed colleagues in the field, including Sondra Schlesinger and Mark Edward Peeples. These partnerships have provided a foundation for cross-disciplinary approaches in research and innovation, allowing for the shared pursuit of advancements in medical science.
Conclusion
In conclusion, Paul D. Olivo stands out as a vital contributor to the field of autoantibody detection, with patents that hold the potential to revolutionize diagnosis and treatment in related diseases. His dedication to innovation and collaboration underscores the importance of continuous progress in healthcare technology, promising better outcomes for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile